Sanofi SA
Company Profile
Business description
Sanofi develops and markets drugs with a concentration in oncology, immunology, cardiovascular disease, diabetes, over-the-counter treatments and vaccines. However, the company's decision in late 2019 to pull back from the cardio-metabolic area will likely reduce the firm's footprint in this large therapeutic area. The company offers a diverse array of drugs with its highest revenue generator, Dupixent, representing just over 20% of total sales, but profits are shared with Regeneron. About 40% of total revenue comes from the United States and 25% from Europe. Emerging markets represent the majority of the remainder of revenue.
Contact
46, avenue de la Grande Armée
Paris 75017
FRAT: +33 153774000
E: investor.relations@sanofi.com
Sector
Healthcare
Stock type
Defensive
Industry
Drug Manufacturers - General
Fiscal Year End
31 December 2024
Employees
87,994
Sanofi SA News & Analysis
stocks
Magnificent Seven vs. the ‘Granolas’: How does Europe’s version stack up?
stocks
10 best US blue-chip shares to buy for the long term
personal-finance
Can you achieve global diversification with multinational companies?
Morningstar Investment Ideas
Stocks
ETFs
- Australian ETFs
- Active Australian Equity ETFs
- Passive Australian Equity ETFs
- Emerging Market Equity ETFs
- Sustainable ETFs
- Active Global Equity ETFs
- Passive Global Equity ETFs
- Active Australian Fixed Interest ETFs
- Passive Australian Fixed Interest ETFs
- Active Australian Listed Property ETFs
- Passive Australian Listed Property ETFs
- Active Global Fixed Interest ETFs
- Passive Global Fixed Interest ETFs
- Active Global Infrastructure ETFs
- Passive Global Infrastructure ETFs
- Active Global Property ETFs
- Passive Global Property ETFs
Funds
- Active Australian Equity Funds
- Passive Australian Equity Funds
- Active Global Equity Funds
- Passive Global Equity Funds
- Sustainable Funds
- Emerging Market Equity Funds
- Passive Australian Listed Property Funds
- Active Australian Listed Property Funds
- Passive Global Infrastructure Funds
- Active Global Infrastructure Funds
- Active Global Property Funds
- Passive Global Property Funds
- Active Australian Fixed Interest Funds
- Passive Australian Fixed Interest Funds
- Active Global Fixed Interest Funds
- Passive Global Fixed Interest Funds
Markets
Index
|
Last price
|
Change
|
% Change
|
|---|---|---|---|
| All Ordinaries | 7,909.00 | 71.60 | 0.91% |
| CAC 40 | 8,088.24 | 71.59 | 0.89% |
| DAX 40 | 18,161.01 | 243.73 | 1.36% |
| Dow JONES (US) | 38,239.66 | 153.86 | 0.40% |
| FTSE 100 | 8,139.83 | 60.97 | 0.75% |
| HKSE | 17,847.22 | 196.07 | 1.11% |
| NASDAQ | 15,927.90 | 316.14 | 2.03% |
| Nikkei 225 | 37,934.76 | 306.28 | 0.81% |
| NZX 50 Index | 11,916.24 | 111.15 | 0.94% |
| S&P 500 | 5,099.96 | 51.54 | 1.02% |
| S&P/ASX 200 | 7,641.60 | 65.70 | 0.87% |
| SSE Composite Index | 3,114.87 | 26.24 | 0.85% |
Market Movers
Name
|
Last price
|
Change
|
% Change
|
|---|---|---|---|
| The Star Entertainment Group Ltd SGR | 0.42 | 0.03 | 7.69% |
| Sayona Mining Ltd SYA | 0.03 | 0.00 | 0.00% |
| Droneshield Ltd DRO | 0.79 | 0.04 | -4.82% |
| Northern Minerals Ltd NTU | 0.03 | 0.00 | 6.25% |
| South32 Ltd S32 | 3.50 | 0.13 | 3.86% |
| Pilbara Minerals Ltd PLS | 3.95 | 0.15 | 3.95% |
| Mesoblast Ltd MSB | 1.07 | 0.14 | 14.52% |
| Telstra Group Ltd TLS | 3.68 | 0.04 | 0.96% |
| Jupiter Mines Ltd JMS | 0.32 | 0.02 | 5.00% |
| Tietto Minerals Ltd TIE | 0.68 | 0.00 | 0.00% |